MKI67 and cancer: The present review focuses on sinonasal malignancies and their management, and it indicates that radiomics can assist clinicians in pre-treatment estimation of Ki-67, in the identification of patients at risk of early recurrence, and in the prediction of response to induction chemotherapy [23,24,25,26,27].